HUBBARD, Ohio--(BUSINESS WIRE)--

NanoLogix Inc. (NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria announces that they will exhibit their microbial detection and diagnostic technologies at both the Food Safety Summit in Baltimore 30 April May 2 and the American Society for Microbiology Annual Meeting in Denver 18-21 May.

The Company will exhibit at booth 924 in the Baltimore Convention Center, Halls A-C.

Further information is available at: http://www.foodsafetysummit.com/

In Denver, the Company will exhibit at booth 1244 in the Colorado Convention Center, Halls A and B. Further information on the event is available at: http://gm.asm.org/

NanoLogix has posted an operations update for 2012-13 at: http://www.nanologix.com.

About NanoLogix, Inc.

NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.

Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity

For more information visit http://www.nanologix.com.

Excerpt from:
NanoLogix to Exhibit at Food Safety Summit in Baltimore and American Society for Microbiology Annual Meeting in Denver